Dr Angus Forster is the Chief Development and Operations Officer at Vaxxas Pty Ltd. Angus has overall responsibility for research, development and operations of Vaxxas. Since 2012, he has grown the Vaxxas R&D team to over 50 scientists, engineers and professional staff, and led early stage clinical studies including two Phase I vaccine clinical trials. He has worked in medical product development and commercialization for 20 years. Prior to Vaxxas, Dr Forster worked in the UK as a consultant for WCI Group and PA Consulting leading compliance improvement and technical product development across medical device, diagnostics and pharma. He brings considerable experience in vaccine development, pharmaceutics, formulation development, analytical science, medical device design and development, risk management and quality systems. Before working as a consultant, Dr Forster commenced his career with GlaxoSmithKline in pharmaceutical development.